Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Daniel Espinouse"'
Autor:
Raphaelle Girard, Catherine Traullé, Nathalie DeSantis, Daniel Espinouse, Sophie Gardes, Bertrand Coiffier
Publikováno v:
Journal of Infection and Public Health, Vol 3, Iss 3, Pp 134-141 (2010)
Summary: Incidence rates of bacteraemia and catheter-related infections were measured prospectively amongst haematological patients having long-term catheters and hospitalised in the ambulatory care unit between November 2005 and October 2006. The fo
Externí odkaz:
https://doaj.org/article/d21682909ee94c8aaec59fa8f1e5e2e1
Autor:
Philippe Moreau, Fabrice Jardin, Jacques-Olivier Bay, Pierre Biron, David Pérol, Catherine Sebban, Philippe Quittet, Bertrand Favier, Christian de Peretti, Aline Schmidt-Tanguy, Lionel Perrier, Daniel Espinouse, Carole Siani, Anne Lefranc, Severine Lissandre
Publikováno v:
Applied Health Economics and Health Policy. 11:129-138
Use of the recombinant human granulocyte colony-stimulating factor (rhG-CSF) filgrastim accelerates neutrophil recovery following myelosuppressive chemotherapy. Since filgrastim requires multiple daily administrations, forms of rhG-CSF with a longer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3844fd735a7b2bfcca7f6d83208afd5
https://doi.org/10.1007/s40258-013-0011-7
https://doi.org/10.1007/s40258-013-0011-7
Autor:
Daciana Antal, Fadhela Bouafia, Catherine Traulle, Catherine Thieblemont, Sophie Tartas, Charles Dumontet, Bernard Lemieux, Daniel Espinouse, Bertrand Coiffier, Emmanuel hornez, Gilles Salles
Publikováno v:
Leukemia & Lymphoma. 45:711-714
Alemtuzumab, the monoclonal anti-CD52 antibody, has clinical activity in B-cell and T-cell malignancies at the dose of 30 mg three times weekly for 9-12 weeks. This standard regimen induced responses usually shorter than 6 months. To prolong time to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765c63a188f69d69639c63b38c0b8868
https://doi.org/10.1080/10428190310001615675
https://doi.org/10.1080/10428190310001615675
Autor:
Bertrand Coiffier, Catherine Thieblemont, Gilles Salles, Olivier Hequet, Jocelyne Drai, Daniel Espinouse, Charles Dumontet, Fadela Bouafia
Publikováno v:
British Journal of Haematology. 112:405-409
Patients receiving high-dose cyclophosphamide as a conditioning regimen for peripheral stem cell collection are subjected over a short period of time to significant exposure to reactive oxygen species (ROS). All these patients undergo profound leucop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ea7c67df67da6d6710ab1c386c68852
https://doi.org/10.1046/j.1365-2141.2001.02595.x
https://doi.org/10.1046/j.1365-2141.2001.02595.x
Autor:
Fadhela Bouafia, Catherine Thieblemont, Charles Dumontet, Olivier Hequet, Daniel Espinouse, Bertrand Coiffier, Gilles Salles
Publikováno v:
Leukemia. 14:2159-2165
Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidation in such patients to determine the feas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2ad240ecb7b2e5154ca9f7344fb844
https://doi.org/10.1038/sj.leu.2401955
https://doi.org/10.1038/sj.leu.2401955
Autor:
Patrice André, Françoise Berger, Daniel Espinouse, Bertrand Coiffier, Gilles Salles, Anna Johnston, Pascale Felman
Publikováno v:
Clinical Lymphoma and Myeloma. 8:356-358
We present the case of a 35-year-old woman with follicular lymphoma who developed an Epstein-Barr virus (EBV)-induced B-cell lymphoproliferation with secondary viral-induced hemophagocytosis 13 months after treatment with rituximab and CHOP (cyclopho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::196823722d1455348b6234e6feebd48b
https://doi.org/10.3816/clm.2008.n.052
https://doi.org/10.3816/clm.2008.n.052
Autor:
EM Neidhardt, Gilles Salles, Catherine Thieblemont, Daniel Espinouse, B. Coiffier, Charles Dumontet, I Moullet, Nicolas Ketterer
Publikováno v:
Bone Marrow Transplantation. 21:1037-1041
Between 1990 and 1997, 55 patients with high risk multiple myeloma underwent high-dose therapy with peripheral blood stem cell transplantation. Intensification consisted of high-dose L-PAM in 54 patients, and 15 patients underwent a second high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2140e4a22f53131d37693ac86c44de9
https://doi.org/10.1038/sj.bmt.1701232
https://doi.org/10.1038/sj.bmt.1701232
Autor:
Sandrine Hayette, Jean-Pierre Magaud, C Ollagnier, Daniel Espinouse, M.H. Bui-Thi, Philippe Rousselot, Emmanuel Raffoux, Kaddour Chabane, Evelyne Callet-Bauchu, Isabelle Tigaud, J M Cayuela, Franck-Emmanuel Nicolini
Publikováno v:
Leukemia. 19:2334-2336
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fcf69e7b087d3c57442a7f8e83b0faf
https://doi.org/10.1038/sj.leu.2403986
https://doi.org/10.1038/sj.leu.2403986
Autor:
Jean-Pierre Marolleau, Felix Reyes, Pauline Brice, Anne Sonet, Daniel Espinouse, Y. Bastion, B. Coiffier, Christian Gisselbrecht, Corinne Haioun, Gilles Salles
Publikováno v:
Europe PubMed Central
Intensive therapy, mainly with purged autologous bone marrow transplantation (ABMT), has been proposed in recent years as consolidation treatment in young patients with follicular lymphoma. Reported experience with transplantation of peripheral blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8214a85d44d20c5fb41111814176fdd6
https://doi.org/10.1182/blood.v86.8.3257.3257
https://doi.org/10.1182/blood.v86.8.3257.3257
Autor:
Laure Lebras, Anne-Sophie Michallet, Pascale Felman, Daniel Espinouse, Lila Gilis, Bertrand Coiffier, Françoise Berger, Gilles Salles, Fadhela Bouafia-Sauvy
Publikováno v:
Leukemialymphoma. 53(8)
Described for the first time by Adachi et al. in 1994 [1], CD4+/CD56+ hematodermic neoplasm was thought to be of natural killer (NK) lineage due to expression of the NK-cell marker CD56 by the tumo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15eaf953d199b2c24a77ba0a43409584
https://pubmed.ncbi.nlm.nih.gov/22260159
https://pubmed.ncbi.nlm.nih.gov/22260159